A comparative study of different strategies for removal of endotoxins from bacteriophage preparations

Journal of Microbiological Methods

Volumn 132, Issue , 2017, Pages 153-159

  Van Belleghem, Jonas D ^a   Merabishvili, Maya ^a,b   Vergauwen, Bjorn ^c   Lavigne, Rob ^d   Vaneechoutte, Mario ^a  

^a GHENT UNIVERSITY   (Belgium)

^b QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^c Central and Eastern Europe   (Belgium)

^d LABORATORY OF GENE TECHNOLOGY   (Belgium)

Author keywords

Bacteriophages; Endotoxin quantification; Endotoxin removal; Endotoxins; Lipopolysaccharides (LPS); Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

ALKALINE PHOSPHATASE; BACTERIAL TOXIN; CESIUM CHLORIDE; ENDOTOXIN; OCTANOL; TRITON X 100; CESIUM; CHLORIDE; DETERGENT; OCTOXINOL; SOLVENT;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BACTERIOPHAGE; CENTRIFUGATION; CHEMICAL PARAMETERS; CHEMICAL PROCEDURES; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME INACTIVATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PURIFICATION; SEPARATION TECHNIQUE; STAPHYLOCOCCUS AUREUS; VALIDATION PROCESS; BACTERIAL COUNT; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; VIROLOGY; VIRUS CULTURE;

BACTERIOPHAGES; CENTRIFUGATION; CESIUM; CHLORIDES; COLONY COUNT, MICROBIAL; DETERGENTS; ENDOTOXINS; OCTOXYNOL; PSEUDOMONAS AERUGINOSA; SOLVENTS; STAPHYLOCOCCUS AUREUS; VIRUS CULTIVATION;

EID: 85006136660     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2016.11.020     Document Type: Article

References (30)

1. Aderem, A., Ulevitch, R., Toll-like receptors in the induction of the innate immune response. Nature, 406, 2000.
2. Adhya, S., Merril, C.R., Biswas, B., Therapeutic and prophylactic applications of bacteriophage components in modern medicine. Cold Spring Harb. Perspect. Med., 4, 2014, a012518, 10.1101/cshperspect.a012518.
3. Adriaenssens, E.M., Lehman, S.M., Vandersteegen, K., Vandenheuvel, D., Philippe, D.L., Cornelissen, A., Clokie, M.R.J., García, A.J., De Proft, M., Maes, M., Lavigne, R., CIM(®) monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particles. Virology 434 (2012), 265–270, 10.1016/j.virol.2012.09.018.
4. Anspach, F.B., Endotoxin removal by affinity sorbents. J. Biochem. Biophys. Methods, 2001, 10.1016/S0165-022X(01)00228-7.
5. Bentala, H., Verweij, W.R., Huizinga-Van der Vlag, A., van Loenen-Weemaes, A.M., Meijer, D.K.F., Poelstra, K., Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 18 (2002), 561–566, 10.1097/01.shk.0000043623.17707.47.
6. Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A.N., Powell, B., Carlton, R., Merril, C.R., Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70 (2002), 204–210, 10.1128/IAI.70.1.204-210.2002.
7. Ceyssens, P.-J., Miroshnikov, K., Mattheus, W., Krylov, V., Robben, J., Noben, J.-P., Vanderschraeghe, S., Sykilinda, N., Kropinski, A.M., Volckaert, G., Mesyanzhinov, V., Lavigne, R., Comparative analysis of the widespread and conserved PB1-like viruses infecting Pseudomonas aeruginosa. Environ. Microbiol. 11 (2009), 2874–2883, 10.1111/j.1462-2920.2009.02030.x.
8. Cooper, C.J., Denyer, S.P., Maillard, J.-Y., Stability and purity of a bacteriophage cocktail preparation for nebulizer delivery. Lett. Appl. Microbiol. 58 (2014), 118–122, 10.1111/lam.12161.
9. Dabrowska, K., Miedzybrodzki, R., Miernikiewicz, P., Figura, G., Gorski, A., Phage Therapy: Current Research and Applications. 2014.
10. Daneshian, M., Guenther, A., Wendel, A., Hartung, T., von Aulock, S., In vitro pyrogen test for toxic or immunomodulatory drugs. J. Immunol. Methods 313 (2006), 169–175, 10.1016/j.jim.2006.04.009.
11. Ding, J.L., Ho, B., Endotoxin detection – from limulus amebocyte lysate to recombinant factor C. Subcellular Biochemistry, 2010, 187–208, 10.1007/978-90-481-9078-2_9.
12. Dufour, N., Henry, M., Ricard, J.-D., Debarbieux, L., Commentary: morphologically distinct Escherichia coli bacteriophages differ in their efficacy and ability to stimulate cytokine release in vitro. Front. Microbiol. 7 (2016), 10–12, 10.3389/fmicb.2016.01029.
13. Erridge, C., Bennett-Guerrero, E., Poxton, I.R., Structure and function of lipopolysaccharides. Microbes Infect., 2002, 10.1016/S1286-4579(02)01604-0.
14. Hou, K.C., Zaniewski, R., Endotoxin removal by anion-exchange polymeric matrix. Biotechnol. Appl. Biochem. 12 (1990), 315–324, 10.1111/j.1470-8744.1990.tb00103.x.
15. Karumidze, N., Thomas, J.a., Kvatadze, N., Goderdzishvili, M., Hakala, K.W., Weintraub, S.T., Alavidze, Z., Hardies, S.C., Characterization of lytic Pseudomonas aeruginosa bacteriophages via biological properties and genomic sequences. Appl. Microbiol. Biotechnol. 94 (2012), 1609–1617, 10.1007/s00253-012-4119-8.
16. Ki, T., Hade, T.S., Mamai, U.W.E., Nter, G., Brade, H., Loepno, H., Pava, F.O.D.I., Bacterial endotoxin: molecular relationship of structure to activity and function. FASEB J. 8 (1994), 217–225.
17. Kutter, E., Sulakvelidze, A., Bacteriophages: biology and applications. N. Y., 2004, 10.1201/9780203491751.
18. Lammens, E., Ceyssens, P.-J., Voet, M., Hertveldt, K., Lavigne, R., Volckaert, G., Representational Difference Analysis (RDA) of bacteriophage genomes. J. Microbiol. Methods 77 (2009), 207–213, 10.1016/j.mimet.2009.02.006.
19. Lavigne, R., Ceyssens, P.-J., Robben, J., Phage proteomics: applications of mass spectrometry. Methods Mol. Biol. 502 (2009), 239–251, 10.1007/978-1-60327-565-1.
20. Ly-Chatain, M.H., The factors affecting effectiveness of treatment in phages therapy. Front. Microbiol. 5 (2014), 1–7, 10.3389/fmicb.2014.00051.
21. Marcus, L., Prusky, D., Effect of particle size of activated charcoal on separation of Triton X-100 from protein, liver cytosol, and lipoxygenase extracts. Anal. Biochem. 163 (1987), 112–116.
22. Merabishvili, M., Pirnay, J., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., Glonti, T., Krylov, V., Mast, J., Van Parys, L., Lavigne, R., Volckaert, G., Mattheus, W., Verween, G., De Corte, P., Rose, T., Jennes, S., Zizi, M., De Vos, D., Vaneechoutte, M., Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One, 2009, 4, 10.1371/journal.pone.0004944.
23. Miedzybrodzki, R., Borysowski, J., Weber-Dabrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., Pawełczyk, Z., Rogóz, P., Kłak, M., Wojtasik, E., Górski, A., Clinical aspects of phage therapy. Adv. Virus Res. 83 (2012), 73–121, 10.1016/B978-0-12-394438-2.00003-7.
24. Miernikiewicz, P., Dabrowska, K., Piotrowicz, A., Owczarek, B., Wojas-Turek, J., Kicielińska, J., Rossowska, J., Pajtasz-Piasecka, E., Hodyra, K., Macegoniuk, K., Rzewucka, K., Kopciuch, A., Majka, T., Letarov, A., Kulikov, E., Maciejewski, H., Górski, A., T4 phage and its head surface proteins do not stimulate inflammatory mediator production. PLoS One 8 (2013), 1–13, 10.1371/journal.pone.0071036.
25. Ogikubo, Y., Norimatsu, M., Noda, K., Takahashi, J., Inotsume, M., Tsuchiya, M., Tamura, Y., Evaluation of the bacterial endotoxin test for quantification of endotoxin contamination of porcine vaccines. Biologicals 32 (2004), 88–93, 10.1016/j.biologicals.2004.05.001.
26. Petsch, D., Anspach, F.B., Endotoxin removal from protein solutions. J. Biotechnol. 76 (2000), 97–119, 10.1016/S0168-1656(99)00185-6.
27. Szermer-Olearnik, B., Boratyński, J., Removal of endotoxins from bacteriophage preparations by extraction with organic solvents. PLoS One, 10, 2015, e0122672, 10.1371/journal.pone.0122672.
28. Thiel, K., Old dogma, new tricks—21st century phage therapy. Nat. Biotechnol. 22 (2004), 31–36, 10.1038/nbt0104-31.
29. Vandenheuvel, D., Lavigne, R., Brüssow, H., Bacteriophage therapy: advances in formulation strategies and human clinical trials. Annu. Rev. Virol. 2 (2015), 599–618, 10.1146/annurev-virology-100114-054915.
30. Vandersteegen, K., Mattheus, W., Ceyssens, P., Bilocq, F., De Vos, D., Pirnay, J.-P., Noben, J.-P., Merabishvili, M., Lipinska, U., Hermans, K., Lavigne, R., Microbiological and molecular assessment of bacteriophage ISP for the control of Staphylococcus aureus. PLoS One, 6, 2011, 10.1371/journal.pone.0024418.